Arkolith/Insider Trading/CORT/Form 4

Guyer William

Chief Development OfficerCORCEPT THERAPEUTICS INC (CORT) · full profile →Form 4 · filed May 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.0M
Net Open-Market Flow
-$1.0M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 5, 2026Option exercise(M)20K$21.65$433K22K
May 5, 2026Sell(S)20K$51.83$1.0M2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 5, 2026Option exercise(M)20K—$0170K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-212118) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML